Azitra AZTR
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Business overview of Azitra (AZTR)
Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.
Key Insights
Critical company metrics and information
Latest Closing Price
$0.35Market Cap
$5.24 MillionPrice-Earnings Ratio
-0.15Total Outstanding Shares
14.98 Million SharesTotal Employees
12Dividend
No dividendIPO Date
June 16, 2023SIC Description
Pharmaceutical PreparationsPrimary Exchange
American Stock ExchangeType
Common StockHeadquarters
21 business park drive, suite 6, Branford, CT, 06405Homepage
https://www.azitrainc.com
Historical Stock Splits
If you bought 30 shares of AZTR before July 1, 2024, you'd have 1 share today.
| Execution Date | Split Amount |
|---|---|
| July 1, 2024 | 1-for-30 (Reverse Split) |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Financing Activities | $13.32 Million |
| Net Cash Flow From Investing Activities | $-379,246 |
| Net Cash Flow From Operating Activities, Continuing | $-10.18 Million |
| Net Cash Flow, Continuing | $2.76 Million |
| Net Cash Flow From Operating Activities | $-10.18 Million |
| Net Cash Flow | $2.76 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Income/Loss | $-8.97 Million |
| Basic Average Shares | $3.78 Million |
| Diluted Average Shares | $3.78 Million |
| Benefits Costs and Expenses | $8.97 Million |
| Other Operating Expenses | $6.27 Million |
| Operating Income/Loss | $-10.99 Million |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss | $-8.97 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Comprehensive Income/Loss Attributable To Parent | $-8.97 Million |
| Other Comprehensive Income/Loss | $0 |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Current Assets | $5.23 Million |
| Noncurrent Assets | $2.13 Million |
| Other Current Liabilities | $885,602 |
| Other Current Assets | $4.66 Million |
| Equity | $5.70 Million |
| Fixed Assets | $653,957 |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||
Recent Headlines From The Web
Latest news, press releases, and media coverage about AZTR from trusted financial sources
ⓒ 2025 Financhle. All Rights Reserved.